OTCMKTS:ZYXI - Zynex Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $3.33 +0.18 (+5.71 %) (As of 01/18/2019 04:00 PM ET)Previous Close$3.33Today's Range$3.10 - $3.3552-Week Range$2.40 - $5.50Volume46,470 shsAverage Volume17,924 shsMarket Capitalization$104.86 millionP/E Ratio15.14Dividend YieldN/ABeta0.81 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Zynex, Inc., a medical technology company, designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. Its products include NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. The company also distributes private labeled products, such as electrodes for the delivery of electrical current to the body; batteries for use in electrotherapy products; Comfortrac for cervical traction; JetStream for hot/cold therapy; and LSO Back Braces for lumbar support. In addition, it develops non-invasive blood volume monitors for use in hospitals and surgery centers. The company offers its products for pain management and control; and stroke and spinal cord injury rehabilitation. It sells its products through direct and independent sales representatives primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Receive ZYXI News and Ratings via Email Sign-up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ZYXI Previous Symbol CUSIPN/A Webwww.zynexmed.com Phone303-703-4906Debt Debt-to-Equity RatioN/A Current Ratio3.45 Quick Ratio3.23Price-To-Earnings Trailing P/E Ratio15.14 Forward P/E Ratio11.89 P/E GrowthN/A Sales & Book Value Annual Sales$23.43 million Price / Sales4.73 Cash Flow$0.2626 per share Price / Cash Flow12.68 Book Value$0.15 per share Price / Book22.20Profitability EPS (Most Recent Fiscal Year)$0.22 Net Income$7.36 million Net Margins33.33% Return on Equity152.81% Return on Assets95.46%Miscellaneous Employees109 Outstanding Shares33,290,000Market Cap$104.86 million OptionableNot Optionable Zynex (OTCMKTS:ZYXI) Frequently Asked Questions What is Zynex's stock symbol? Zynex trades on the OTCMKTS under the ticker symbol "ZYXI." How were Zynex's earnings last quarter? Zynex Inc. (OTCMKTS:ZYXI) released its quarterly earnings data on Tuesday, November, 6th. The company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.07 by $0.01. The firm earned $8.13 million during the quarter, compared to the consensus estimate of $7.96 million. Zynex had a net margin of 33.33% and a return on equity of 152.81%. View Zynex's Earnings History. What price target have analysts set for ZYXI? 1 brokerages have issued 12-month target prices for Zynex's stock. Their predictions range from $7.00 to $7.00. On average, they anticipate Zynex's stock price to reach $7.00 in the next year. This suggests a possible upside of 110.2% from the stock's current price. View Analyst Price Targets for Zynex. What is the consensus analysts' recommendation for Zynex? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zynex. Has Zynex been receiving favorable news coverage? Headlines about ZYXI stock have trended somewhat positive recently, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Zynex earned a media sentiment score of 1.7 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. Who are some of Zynex's key competitors? Some companies that are related to Zynex include Semler Scientific (SMLR), BioLife Solutions (BLFS), Cutera (CUTR), Rockwell Medical (RMTI), Electrocore (ECOR), Fonar (FONR), Stereotaxis (STXS), Biosig Technologies (BSGM), Edap Tms (EDAP), IRIDEX (IRIX), Second Sight Medical Products (EYES), Soleno Therapeutics (SLNO), Viveve Medical (VIVE), Digirad (DRAD) and Precision Optics (PEYE). Who are Zynex's key executives? Zynex's management team includes the folowing people: Mr. Thomas Sandgaard, Founder, Pres, CEO & Chairman (Age 60)Mr. Daniel J. Moorhead, Chief Financial Officer (Age 47)Mr. David B. Mogill, VP of OperationsMr. Robert Bird, VP of MarketingMr. Steve Siefring, Director of Bus. Devel. How do I buy shares of Zynex? Shares of ZYXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Zynex's stock price today? One share of ZYXI stock can currently be purchased for approximately $3.33. How big of a company is Zynex? Zynex has a market capitalization of $104.86 million and generates $23.43 million in revenue each year. The company earns $7.36 million in net income (profit) each year or $0.22 on an earnings per share basis. Zynex employs 109 workers across the globe. What is Zynex's official website? The official website for Zynex is http://www.zynexmed.com. How can I contact Zynex? Zynex's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The company can be reached via phone at 303-703-4906 or via email at [email protected] MarketBeat Community Rating for Zynex (OTCMKTS ZYXI)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 84 (Vote Outperform)Underperform Votes: 77 (Vote Underperform)Total Votes: 161MarketBeat's community ratings are surveys of what our community members think about Zynex and other stocks. Vote "Outperform" if you believe ZYXI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZYXI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/19/2019 by MarketBeat.com StaffFeatured Article: What are defining characteristics of a correction?